Group 1 - The company announced the expiration of the sixth board of directors' term and plans to hold an employee representative meeting on February 11, 2026, to elect the seventh board of directors' employee director [1] - Lin Changchun was elected as the employee director of the seventh board of directors through a democratic vote, with the term aligning with that of the seventh board [1]

格隆汇2月11日｜紫光股份公告，公司决定终止筹划发行H股股票并在香港联交所主板上市。公司本次 终止发行H股股票事项不会对公司的经营活动造成重大影响，敬请广大投资者注意投资风险。 ...

格隆汇2月11日丨安邦护卫(603373.SH)公布，公司近日收到公司非独立董事卢卫东先生提交的书面辞职 报告。卢卫东先生因岗位调动，申请辞去公司第二届董事会非独立董事、董事会法治与合规委员会委员 职务。 ...

格隆汇2月11日丨紫光股份(000938.SZ)公布，拟向特定对象发行A股股票募集资金总额不超过55.7亿元 （含本数），扣除发行费用后的净额投资于收购新华三6.98%股权、研发设备购置项目、偿还银行贷 款。 如何抓住黄金波段机会？聪明钱的选择，黄金+股票一键搞定>> ...

格隆汇2月11日丨紫光股份(000938.SZ)公布，根据公司战略发展规划等情况，本着维护股东利益、对股 东负责的原则，经公司审慎分析和论证，公司于2026年2月11日召开第九届董事会第二十次会议，审议 通过了《关于公司终止发行H股股票并于香港联合交易所有限公司主板上市的议案》，公司决定终止筹 划发行H股股票并在香港联交所主板上市。公司本次终止筹划H股股票事项属于股东会授权董事会全权 处理的授权范围，无需提交股东会审议。 ...

Core Viewpoint - Watson Bio (300142.SZ) has announced the establishment of the Yunnan Chuangwo Biological Industry Investment Fund in collaboration with several partners, aiming for a target size of 1 billion yuan, with the company contributing 450 million yuan as a limited partner [1] Group 1: Investment Fund Details - The fund's target size is set at 1 billion yuan [1] - Watson Bio will invest 450 million yuan of its own funds as a limited partner [1] - The fund will focus on various investment areas including synthetic biology, life and health, biological agriculture, bioenergy, biomaterials, technology platform enterprises, and high-throughput equipment [1] Group 2: Investment Areas - Investment areas include synthetic biology such as enzyme preparations, amino acids, and probiotics [1] - Life and health investments will cover plant extracts, recombinant collagen, sweeteners, and protein drugs [1] - Biological agriculture will focus on feed protein, micro-ecological preparations, animal vaccines, and biological nitrogen fixation [1] - Bioenergy investments will include bioethanol and biodiesel [1] - Biomaterials will focus on PLA, PHA, and PDO [1] - The fund will also target technology platform enterprises like strain development and AI protein design [1] - High-throughput equipment investments will include microfluidic devices and gene sequencing equipment [1]

Core Viewpoint - Yinhui Technology (300221.SZ) aims to enhance asset utilization efficiency by selling specialized equipment for 7.1546 million yuan to Yutong (Dongguan) Automation Technology Co., Ltd. [1] Group 1 - Yinhui Technology's subsidiary, Dongguan Zhongyao Electric Technology Co., Ltd., is involved in the sale of specialized equipment [1] - The transaction was executed at market price, indicating a strategic move to optimize resource allocation [1] - A purchase contract has been signed with Yutong Automation, and the payment for the equipment has been received [1]

Core Insights - NetEase reported steady performance for Q4 2025, with revenue reaching 27.5 billion yuan and total annual revenue of 112.6 billion yuan [1] - The company achieved an operating profit of 35.8 billion yuan for the year, reflecting a year-on-year growth of 21%, while Q4 operating profit was 8.3 billion yuan, up 6% year-on-year [1] - Research and development investment reached 17.7 billion yuan, marking the sixth consecutive year of R&D spending exceeding 10 billion yuan [1] - The net income from games and related value-added services was 92.1 billion yuan, with online gaming net income at 89.6 billion yuan, showing an 11% year-on-year increase [1]

格隆汇2月11日丨山大地纬(688579.SH)公布，为充分发挥山东高速集团、山大资本的资源优势，积极促 进山大地纬与股东之间的协同效用，实现公司提质发展，公司控股股东山东高速集团、公司股东山大资 本于2026年2月10日签署了《一致行动人协议》，对双方在公司股东会、董事会及经营管理中采取一致 行动及具体方案进行了约定。 截至本公告披露日，山东高速集团直接持有公司24.59%股份，拥有公司24.59%的股份表决权；山大资 本直接持有公司4.99%股份，拥有公司4.99%的股份表决权。综上，山东高速集团、山大资本控制公司 表决权比例合计为29.58%。 ...

Core Viewpoint - The company has decided to terminate its participation in the capital increase of the Greenmei Indonesia project due to changes in the current internal and external circumstances, following careful research and friendly consultations [1] Group 1 - The company held its seventh board meeting on February 11, 2026, where it approved the resolution to terminate its participation in the capital increase of the Greenmei Indonesia project [1] - The company has signed the termination agreement for PTINDONESIA QINGMEI ENERGY MATERIALS and authorized its management to handle subsequent related matters, including signing the termination agreement [1]